Literature DB >> 11085808

Clinical and laboratory features of scleroderma patients with pulmonary hypertension.

K Yamane1, H Ihn, Y Asano, N Yazawa, M Kubo, K Kikuchi, Y Soma, K Tamaki.   

Abstract

OBJECTIVE: Pulmonary hypertension (PH) is a frequent cause of death in patients with systemic sclerosis (SSc). In this study, we examined the occurrence of PH and investigated the clinical and laboratory features of SSc patients with PH.
METHODS: A cross-sectional study of 125 Japanese patients with SSc was conducted using Doppler echocardiography, other multiple cardiopulmonary tests, and laboratory examination.
RESULTS: PH (systolic pressure >40 mmHg) was diagnosed in 20 patients (16%) by Doppler echocardiography. In the six patients who had secondary pulmonary hypertension (SPH), PH was due to severe pulmonary fibrosis; 14 patients had isolated pulmonary hypertension (IPH). An elevated erythrocyte sedimentation rate (ESR) and increased immunoglobulin G (IgG) were found in a significantly greater proportion of the patients with PH than in those without PH. The incidence of pitting scars/ulcers was significantly greater in the patients with SPH than in those without PH.
CONCLUSION: Elevated ESR and increased IgG were common features of scleroderma patients with PH, and scleroderma patients with SPH were inclined to have pitting scars/ulcers.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11085808     DOI: 10.1093/rheumatology/39.11.1269

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  6 in total

1.  Pulmonary hypertension in a patient with adult-onset Stills disease.

Authors:  Eisha Mubashir; M Mubashir Ahmed; Samina Hayat; Maureen Heldmann; Seth Mark Berney
Journal:  Clin Rheumatol       Date:  2006-07-27       Impact factor: 2.980

2.  Clinical features of scleroderma patients with contracture of phalanges.

Authors:  Ryuichi Ashida; Hironobu Ihn; Yoshihiro Mimura; Masatoshi Jinnin; Yoshihide Asano; Masahide Kubo; Kunihiko Tamaki
Journal:  Clin Rheumatol       Date:  2006-12-15       Impact factor: 2.980

3.  Serum levels of soluble CD163 in patients with systemic sclerosis.

Authors:  Wakana Nakayama; Masatoshi Jinnin; Katsunari Makino; Ikko Kajihara; Takamitsu Makino; Satoshi Fukushima; Yuji Inoue; Hironobu Ihn
Journal:  Rheumatol Int       Date:  2010-12-01       Impact factor: 2.631

Review 4.  Scleroderma lung disease.

Authors:  Joshua J Solomon; Amy L Olson; Aryeh Fischer; Todd Bull; Kevin K Brown; Ganesh Raghu
Journal:  Eur Respir Rev       Date:  2013-03-01

5.  Oxidative stress in Mexicans with diffuse cutaneous systemic sclerosis.

Authors:  M P Cruz-Domínguez; D H Montes-Cortes; I M Olivares-Corichi; O Vera-Lastra; G Medina; L J Jara
Journal:  Rheumatol Int       Date:  2013-03-02       Impact factor: 2.631

Review 6.  Prevalence of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review of the literature.

Authors:  Xiaoqin Yang; Jack Mardekian; Kafi N Sanders; Marko A Mychaskiw; Joseph Thomas
Journal:  Clin Rheumatol       Date:  2013-06-20       Impact factor: 2.980

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.